Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial
by Mirza, Mansoor R. (Author)
, Bjørge, Line (Author)
, Marmé, Frederik (Author)
, Christensen, René DePont (Author)
, Gil-Martin, Marta (Author)
, Auranen, Annika (Author)
, Ataseven, Beyhan (Author)
, Rubio, Maria Jesús (Author)
, Salutari, Vanda (Author)
, Luczak, Adam A. (Author)
, Runnebaum, Ingo B. (Author)
, Redondo, Andrés (Author)
, Lindemann, Kristina (Author)
, Trillsch, Fabian (Author)
, Ginesta, M. Pilar Barretina (Author)
, Roed, Henrik (Author)
, Kurtz, Jean-Emmanuel (Author)
, Petersson, Karen S. (Author)
, Nyvang, Gitte-Bettina (Author)
, Sehouli, Jalid (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource